Skip to main content
. 2009 Mar 17;14(3):106–112. doi: 10.1186/2047-783X-14-3-106

Table 3.

Demographic data and medication in the LDHF and HDHF groups

LDHF (n = 22) HDHF (n = 18) sign.
Age (years) 59 (38-64) 60 (39-78) n.s.
Weight (kg) 86 (70 - 115) 82 (63-91) n.s.
Height (cm) 180 (160 - 190) 172 (160-185) n.s.
Male/Female 21/1 14/4 n.s.
LVEF [%] 60 (20 - 65) 45 (30 - 60) n.s.
Previous MI [yes/no] 18/4 10/8 n.s.
Previous CABG [yes/no] 10/22 9/18 n.s
Previous PCI [yes/no] 11/22 10/18 n.s.
Pos. ischemia testing [yes/no] 0/22 5/13 p = 0.013
Duration of IHD [months] 1 (1-50) 2 (1 - 120) n.s.
Betablocker [yes/no] 22/0 18/0 n.s.
ACE-inhibitor/ARB [yes/no] 17/5 17/1 n.s.
Diuretics [yes/no] 5/17 9/9 (p = 0.08)
Aldosterone-Blocker [yes/no] 0/22 1/17 n.s.
Digitalis [yes/no] 2/20 7/11 p = 0.025

Demographic data and medication of patients with ischemic heart disease (IHD) grouped according to the results of ergometric exercise testing in a high degree heart failure (HDHF) and a low degree heart failure group (LDHF). Data are median ± range. LVEF: left ventricular ejection fraction (echocardiograpy); MI: myocardial infarction; CABG: coronary artery bypass grafting; PCI: percutaneus coronary intervention; positive ischemia testing: please see text for details; ARB: angiotensin receptor blocker. p < 0.05: significant between group difference (continuous data: Mann-Whitney U, nominal data: Fisher's exact test).